Based on this YouTube video's total view count of 279 views and industry-standard rates, the estimated total earning is $0 - $1 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Life Sciences Virtual Investor Forum — Phio Pharmaceuticals Corp. (Nasdaq: PHIO) with 279 views, 0 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.

This video is part of the ⁨@OTCMarketsGroup⁩ Life Sciences Virtual Investor Forum by Virtual Investor Conferences, a ⁨@b2idigital⁩ Featured Conference, held on March 11th & 12th, 2026. Phio Pharmaceuticals is developing therapeutics using INTASYL, a chemically modified siRNA technology designed to silence specific genes that hinder the immune system’s ability to fight cancer, with a focus on immuno-oncology. Unlike many siRNA approaches that rely on complex delivery systems such as lipid nanoparticles, INTASYL compounds are engineered to self-deliver into cells without additional formulations, simplifying administration and potentially reducing toxicity. Watch the full Phio Pharmaceuticals Corp. (Nasdaq: PHIO) presentation and request meetings with management at: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5269944/phio-pharmaceuticals-corp-nasdaq-phio?utm_source=b2i&utm_medium=marketing&utm_campaign=0326LifeSciencesVIC Any questions or need assistance setting up meetings, contact Joseph Azizo, Capital Markets Associate at B2i Digital: [email protected]

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.